P‐glycoprotein Interactions of Nefazodone and Trazodone in Cell Culture
- 1 July 2001
- journal article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 41 (7) , 708-714
- https://doi.org/10.1177/00912700122010609
Abstract
This study investigated the effects of nefazodone (NFZ) and trazodone (TZD) on P-glycoprotein (P-gp) activity and expression in cell culture. NFZ and TZD showed no differential transport between the basolateral to apical and apical to basolateral direction across Caco-2 cell monolayers. Transport in either direction was not affected by verapamil. NFZ was a potent inhibitor (IC50 = 4.7 microM) of rhodamine123 (Rh123) B to A transport across Caco-2 cell monolayers, while TZD had minimal effect. Following 72-hour exposure of LS180V cells to NFZ and TZD (10 microM), a twofold increase in immunoreactive P-gp was observed. Rh123 accumulation into these cells was reduced to 65% and 74% of control by NFZ and TZD (10 microM), respectively. It was concluded that differential rates of transport of NFZ and TZD in Caco-2 cells were not evident. However, NFZ is an inhibitor of P-gp activity at clinically relevant in vivo concentrations and may have the potential to increase bioavailability of coadministered compounds that are substrates for transport. Concentrations of NFZ and TZD achieved in the intestine after chronic oral dosing may induce P-gp expression and reduce absorption of coadministered drugs.Keywords
This publication has 38 references indexed in Scilit:
- In vitro metabolism of trazodone by CYP3A: inhibition by ketoconazole and human immunodeficiency viral protease inhibitorsBiological Psychiatry, 2000
- Nefazodone and cyclosporine drug–drug interactionThe Journal of Heart and Lung Transplantation, 1999
- Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actionsPsychopharmacology, 1999
- Dangerous interaction with nefazodone added to fluoxetine, desipramine, venlafaxine, valproate and clonazepam combination therapyJournal of Psychopharmacology, 1997
- Caco-2 monolayers in experimental and theoretical predictions of drug transportAdvanced Drug Delivery Reviews, 1996
- Development of intestinal cell culture models for drug transport and metabolism studiesAdvanced Drug Delivery Reviews, 1996
- Investigation of Pharmacokinetic and Pharmacodynamic Interactions After Coadministration of Nefazodone and HaloperidolJournal of Clinical Psychopharmacology, 1996
- Assessment of Pharmacokinetic and Pharmacodynamic Drug Interactions between Nefazodone and Digoxin in Healthy Male VolunteersThe Journal of Clinical Pharmacology, 1996
- Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.Proceedings of the National Academy of Sciences, 1989
- TrazodoneDrugs, 1981